Clinical Trial Update: A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment of Schizophrenia [Phase 2]

View source ↗

Summary

This document provides an update on an ongoing Phase II trial evaluating NS-136 for acute schizophrenia, including enrollment status and study design.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• NS-136

Snippet

Sponsor: NeuShen Therapeutics | Conditions: Schizophrenia(Acute) | Phase 2 | Status: ENROLLING_BY_INVITATION